Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Angiopoietin-1 helps hair cells survive and grow, making it a potential treatment for hair loss.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

New biological pathways and potential treatment targets for male pattern baldness were identified.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Moxibustion may help improve ovarian function by changing androgen levels.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Androgen use may increase the risk of stroke, but more research is needed.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

A new gene, JMJD1C, may affect testosterone levels in men.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Gene variation affects prostate issues and hair loss.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.